Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

NN-304, a long-acting insulin analogue in preclinical testing

June 10, 1997

Skelid introduced in the U.S.

June 10, 1997

New antidiabetic agent from Japan Tobacco

June 10, 1997

Agent for gastroparesis in diabetic patients

June 10, 1997

Studies reported on absorption of the insulin analogue HOE-901

June 10, 1997

BRL-49653: Profile of a potential new antidiabetic agent

June 10, 1997

BTS-67582 preclinical and clinical trials results

June 10, 1997

Promising clinical results reported for Flt3 ligand as stem cell mobilizer

June 9, 1997

TKT reaches milestone in second Gene Activation collaboration with HMR

June 9, 1997

Phase III results with Lilly's raloxifene reported

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...